Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 152 participants.
Also called NCT06765265
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Phase 4
- Enrolled
- 152 participants
- Registry
-
NCT06765265
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Pakistan
- Registry status
- Recruiting
Technical summary
Registry record NCT06765265. Randomized; no masking; primary purpose supportive care. Start 2025-01-05 (actual); primary completion 2026-01-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
- Condition
- Acute Coronary Syndromes
- Intervention (Drug)
- Rosuvastatin 20 mg/day
- Intervention (Drug)
- Atorvastatin 40 mg
- Lead sponsor
- King Edward Medical University
Record details
- Record id
cardio:ct-nct06765265- Content hash
e92a19c024aaa95f93358b1137f47ddc052555aff5958cf363b575831a307d7d